All Viruses articles – Page 95
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsCOVID-19 infection disrupts gut microbes, especially with antibiotics
Acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment, researchers have found.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
-
NewsHidden Nsp1 cavity means Covid’s Spike protein is no longer the only target
Researchers have revealed the existence of a hidden ’’pocket’ on the surface of the non-structural protein Nsp1 on the surface of the Covid-19 virus which could offer a potential drug target and alternative to the Spike protein targeted by vaccines.
-
NewsGene-delivering viruses cross into brain in step toward gene therapy for neurological diseases
A family of adeno-associated viruses (AAVs) has been developed that are capable of delivering gene therapies to the brain, a particularly challenging target tissue.
-
NewsHIV infection leaves memory that persists in cells even when virus is gone
A new study explains why people living with HIV may suffer from chronic inflammation, which can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction and how suppression or even eradication of HIV in the body may not resolve it. ...
-
NewsCOVID-19 reanimates latent viruses in cells – particularly in ME patients
Researchers have found that COVID-19 reactivates viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.
-
NewsAMI’s pitch on bacteriophages is winner of My Science Inquiry
Applied Microbiology International’s pitch to explore bacteriophages as an alternative to antimicrobial drugs has been selected by the Commons Science and Technology Committee as the winner of the My Science inquiry.
-
NewsViruses deploy CRISPR system to thwart bacterial defences
Researchers have shown that viruses engineered with a CRISPR-Cas system can thwart bacterial defenses and make selective changes to a targeted bacterium – even when other bacteria are in close proximity.
-
NewsBird flu ‘could hit food availability in run-up to Christmas’
Kingston University Professor of Medical Microbiology Mark Fielder explains why the current strain of avian influenza is so contagious, how best to control the spread and the effect the outbreak is having on farmers, retailers and the UK economy.
-
NewsCoffee compound could offer protection from catching COVID-19
Researchers have shown that a compound found in coffee could help to protect against infection by Covid-19.
-
NewsMonkeypox mutations cause virus to spread rapidly and dodge vaccines
Researchers at the University of Missouri have identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness.
-
NewsDrug used against herpes could be latest weapon to tackle Klebsiella
Scientists reveal that a drug used against herpes can fight a bacterium that is resistant to most antibiotics by weakening its defence mechanisms.
-
NewsNew monkeypox study increases fear of potential escalation in central Africa
A new study of monkeypox infections in a remote area of the Democratic Republic of the Congo (DRC) shows transmission rates rising closer to the point where outbreaks are likely to be larger and more frequent.
-
FeaturesUnder the microscope: langya virus
The novel zoonotic virus known as “Langya henipavirus” (LayV) was discovered in 2022.
-
Long ReadsUnder the microscope: monkeypox
Human monkeypox infection is a zoonotic disease caused by monkeypox virus which belongs to the Orthopoxvirus genus of the Poxviridae family
-
NewsCOVID-19 virus increases risk of other infections by disrupting normal mix of gut bacteria
Infection with Covid-19 can reduce the number of bacterial species in a patient’s gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study has found.
-
NewsNew research reveals wastewater treatment plants can catch a virus
Research from Chalmers University of Technology, Sweden, reveals the implications for the surrounding environment iif a waste water treatment plant comes under viral attack.
-
NewsExperimental monoclonal antibodies take the fight to Epstein-Barr virus
Researchers have discovered a panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting.